The roles of hornerin in tumor progression or vascularity in several cancers including breast cancer [40, 41], hepatocellular carcinoma [42] and pancreatic ductal carcinoma [43] have been investigated. Here, HRNR is linked to pancreatic ductal adenocarcinoma.